Influenza News and Research

Latest Influenza News and Research

AnteoTech's COVID-19 antigen and Flu A&B test detects SARS-Cov-2, influenza in less than 15 minutes

AnteoTech Ltd has successfully developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests that can detect the presence of SARS-Cov-2 and influenza in less than 15 minutes.

21 Aug 2020

Macaques show low neutralizing antibody and cellular immune response to SARS-CoV-2

A new study published on the preprint server bioRxiv* in August 2020 presents a cynomolgus macaque model that develops symptomatic SARS-CoV-2 infection in a mild form, with low or no antibody responses, making it suitable to study human responses to vaccines and drugs targeting the virus.

21 Aug 2020

Lack of consistency in COVID-19-related data could harm prevention efforts

Since COVID-19 emerged late last year, there's been an enormous amount of research produced on this novel coronavirus disease.

20 Aug 2020

Influenza A virus can spread by airborne aerosolized fomites, finds study

Viruses like the influenza virus and even the novel coronavirus are capable of spreading from person to person via airborne droplets as well as dust, fibers, and other surfaces. Now, a new study provides evidence of airborne virus transport on microscopic particles called “aerosolized fomites.”

20 Aug 2020

Study evaluates the reliability of new serological assays for detecting SARS-CoV-2 antibodies

Approximately four months after the initial description of cases of atypical pneumonia in Wuhan, China, in December 2019, COVID-19 had become a major pandemic threat.

20 Aug 2020

New hybrid mask allows ENTs to see more patients

An ear, nose, and throat doctor has invented a simple mask design that significantly improves safety during aerosol-generating procedures of the head and neck.

20 Aug 2020

COVID-19 could compromise key element of immune response

Researchers at the University of Melbourne have made the unsettling discovery that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might compromise the activation of the CD8+ T-cell responses that would usually ameliorate disease and drive recovery in cases of respiratory disease.

20 Aug 2020

Low indoor air humidity increases spread of SARS-CoV-2

The airborne transmission of the coronavirus SARS-CoV-2 via aerosol particles in indoor environment seems to be strongly influenced by relative humidity.

20 Aug 2020

Children play a larger role in the community spread of COVID-19 than previously thought

In the most comprehensive study of COVID-19 pediatric patients to date, Massachusetts General Hospital (MGH) and Mass General Hospital for Children (MGHfC) researchers provide critical data showing that children play a larger role in the community spread of COVID-19 than previously thought

20 Aug 2020

SARS-CoV-2 hijacks antiviral factors to promote infection in human lung cells

Now, a new study published in the preprint server bioRxiv in August 2020 shows that under conditions resembling those in vivo, IFNs may promote efficient viral invasion instead.

20 Aug 2020

Mathematical modeling helps researchers track and tackle COVID-19 pandemic

The Editor-in-Chief Vitaly Volpert of the Institut Camille Jordan, University ofLyon, France, reviews how the public's new favourite scientific discipline, mathematical modelling, is being used to track and tackle the COVID-19 pandemic.

19 Aug 2020

Winter is not the time to become complacent about COVID-19

We are delighted to see the reduction in the number of cases of SARS-CoV-2 infection occurring in the United Kingdom in recent weeks, with currently 1 in 1900 people in the UK having coronavirus infection.

19 Aug 2020

Gut microbiome may play a part in severe COVID-19

A recent study published on the preprint medRxiv* in August 2020 reports on the evidence that the gut microbiome may play a part in severe COVID-19 infection.

19 Aug 2020

Antibody and cellular immunity in severe vs. mild COVID-19

Now, a new study published in the journal Signal Transduction and Targeted Therapy in August 2020 shows that while humoral and T-cell immune responses are more robust in severe infection, the disease activates memory T cells as part of the adaptive immune system in COVID-19 patients irrespective of disease severity.

18 Aug 2020

Influenza viruses can spread through dust, fibers, and other microscopic particles

Influenza viruses can spread through the air on dust, fibers and other microscopic particles, according to new research from the University of California, Davis and the Icahn School of Medicine at Mt. Sinai.

18 Aug 2020

Study shows coronavirus thrives in dry air with low humidity

A new study by researchers from the University of Sydney and the Fudan University School of Public Health in Shanghai suggests that low humidity increases the risk of spreading the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

18 Aug 2020

Pigs appear to be immune to SARS-CoV-2

Now, a team of researchers at Kansas State University aimed to determine if pigs are potential carriers of SARS-CoV-2, the virus that causes the coronavirus disease (COVID-19).

18 Aug 2020

New technique enables real-time observation of influenza A hemagglutinin during viral entry

Unlike living organisms, to avoid extinction, viruses need to hijack living host machineries to generate new viruses.

17 Aug 2020

Wits University begins South African trial of Novavax COVID-19 vaccine

NVX-CoV2373 is produced by the biotech company, Novavax (Maryland, U.S.A). Novavax is a late-stage biotechnology company that develops next-generation vaccines for serious infectious diseases.

17 Aug 2020

Social distancing reduced ER visits and respiratory tract infections in Finnish children

Finland declared a lockdown in response to the coronavirus pandemic in March 2020, and the ensuing social distancing measures decreased the number of paediatric emergency room visits to nearly one-third of what they used to be, according to a recent register-based study conducted in collaboration between the University of Eastern Finland, Kuopio University Hospital and the National Institute for Health and Welfare.

17 Aug 2020

Influenza News and Research

Latest Influenza News and Research

AnteoTech's COVID-19 antigen and Flu A&B test detects SARS-Cov-2, influenza in less than 15 minutes

Macaques show low neutralizing antibody and cellular immune response to SARS-CoV-2

Lack of consistency in COVID-19-related data could harm prevention efforts

Influenza A virus can spread by airborne aerosolized fomites, finds study

Study evaluates the reliability of new serological assays for detecting SARS-CoV-2 antibodies

New hybrid mask allows ENTs to see more patients

COVID-19 could compromise key element of immune response

Low indoor air humidity increases spread of SARS-CoV-2

Children play a larger role in the community spread of COVID-19 than previously thought

SARS-CoV-2 hijacks antiviral factors to promote infection in human lung cells

Mathematical modeling helps researchers track and tackle COVID-19 pandemic

Winter is not the time to become complacent about COVID-19

Gut microbiome may play a part in severe COVID-19

Antibody and cellular immunity in severe vs. mild COVID-19

Influenza viruses can spread through dust, fibers, and other microscopic particles

Study shows coronavirus thrives in dry air with low humidity

Pigs appear to be immune to SARS-CoV-2

New technique enables real-time observation of influenza A hemagglutinin during viral entry

Wits University begins South African trial of Novavax COVID-19 vaccine

Social distancing reduced ER visits and respiratory tract infections in Finnish children

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Influenza News and Research

Latest Influenza News and Research

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in